Role of membrane cholesterol in differential sensitivity of muscarinic receptor subtypes to persistently bound xanomeline
Open Access
- 1 May 2018
- journal article
- research article
- Published by Elsevier in Neuropharmacology
- Vol. 133, 129-144
Abstract
No abstract availableKeywords
Funding Information
- Czech Academy of Sciences (RVO:67985823)
- Grant Agency of the Czech Republic (14-05696S, 17-16182S)
This publication has 45 references indexed in Scilit:
- Crystal structure of the µ-opioid receptor bound to a morphinan antagonistNature, 2012
- Uncovering the intimate relationship between lipids, cholesterol and GPCR activationCurrent Opinion in Structural Biology, 2011
- Structural Basis of M3 Muscarinic Receptor Dimer/Oligomer FormationJournal of Biological Chemistry, 2011
- Adenosine receptors and membrane microdomainsBiochimica et Biophysica Acta (BBA) - Biomembranes, 2011
- Signaling pathways in schizophrenia: emerging targets and therapeutic strategiesTrends in Pharmacological Sciences, 2010
- Differential Effect of Membrane Cholesterol Removal on μ- and δ-Opioid ReceptorsJournal of Biological Chemistry, 2009
- AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreadingJournal of Computational Chemistry, 2009
- Membrane cholesterol content influences binding properties of muscarinic M2 receptors and differentially impacts activation of second messenger pathwaysEuropean Journal of Pharmacology, 2009
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- Making optimal use of empirical energy functions: Force‐field parameterization in crystal spaceProteins: Structure, Function, and Bioinformatics, 2004